We are live on
!
Find out more
TWM
Trueblood Wealth Management Portfolio holdings
AUM
$256M
1-Year Est. Return
19.59%
This Fund
S&P 500
This Quarter
Est. Return
+1.46%
1 Year Est. Return
+19.59%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$256M
AUM Growth
-$538K
(-0.21%)
Cap. Flow
+$1.76M
Cap. Flow
% of AUM
0.69%
Top 10 Holdings %
Top 10 Hldgs %
21.07%
Holding
265
New
13
Increased
112
Reduced
118
Closed
9
Top Buys
| 1 |
First Trust Morningstar Dividend Leaders Index Fund
FDL
|
+$397K |
| 2 |
Franco-Nevada
FNV
|
+$344K |
| 3 |
Advanced Micro Devices
AMD
|
+$319K |
| 4 |
FT Vest S&P 500 Dividend Aristocrats Target Income ETF
KNG
|
+$309K |
| 5 |
Corteva
CTVA
|
+$300K |
Top Sells
| 1 |
Brown & Brown
BRO
|
+$513K |
| 2 |
Intuit
INTU
|
+$464K |
| 3 |
Boston Scientific
BSX
|
+$440K |
| 4 |
Qualcomm
QCOM
|
+$346K |
| 5 |
UnitedHealth
UNH
|
+$322K |
Sector Composition
| 1 | Technology | 16.68% |
| 2 | Financials | 13.86% |
| 3 | Industrials | 9.88% |
| 4 | Healthcare | 5.87% |
| 5 | Energy | 5.52% |
Similar funds
KAM
HP
CA
WFC
CIA
KIG
2
CIM
Trueblood Wealth Management's Q1 2026 Portfolio in Review
As of Q1 2026, Trueblood Wealth Management held 265 positions worth $256M, down 0.21% from $256M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Trueblood Wealth Management's Q1 2026 filing shows 13 new, 112 increased, 118 reduced and 9 closed positions. Its largest new stake was First Trust Morningstar Dividend Leaders Index Fund: 8,131 shares worth $413K. The largest sale was Brown & Brown, an estimated $513K.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Financials and Industrials.
- Trueblood Wealth Management's largest Q1 2026 buy was First Trust Morningstar Dividend Leaders Index Fund: 8,131 shares worth $413K.
- Trueblood Wealth Management added most to Advanced Micro Devices in Q1 2026, an estimated $319K increase.
- Trueblood Wealth Management's biggest Q1 2026 reduction was Brown & Brown, cutting an estimated $513K.
- Trueblood Wealth Management fully exited Boston Scientific in Q1 2026, selling an estimated $440K.
- Trueblood Wealth Management's ten largest holdings make up 21% of its $256M portfolio in Q1 2026.
- Trueblood Wealth Management opened 13 new positions and closed 9 in Q1 2026.
- Trueblood Wealth Management's portfolio value fell 0.21% quarter-over-quarter to $256M.
Based on Trueblood Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.